Abstract
The present disclosure, in part, relates to novel, aptamers targeting α-synuclein. The present disclosure includes methods for making and methods of using aptamers targeting α-synuclein.
Original language | English |
---|---|
Patent number | US2024124883 |
IPC | C12N 15/ 115 A I |
Priority date | 19/02/22 |
Publication status | Published - 18 Apr 2024 |